Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Mar. 31, 2023	Mar. 31, 2022
Gross Sales	$ 6,584,666	$ 9,948,858	$ 12,825,191	$ 19,805,625
Allowances	(344,646)	(319,972)	(499,954)	(854,917)
Total Net Sales	6,240,020	9,628,886	12,325,237	18,950,708
Cost of sales	2,224,512	3,186,564	4,741,964	7,514,874
Gross Profit	4,015,508	6,442,322	7,583,273	11,435,834
Operating expenses	5,416,151	11,452,700	13,030,097	23,407,984
Impairment of goodwill and other intangible assets	0	0	0	18,183,285
Loss from operations	(1,400,643)	(5,010,378)	(5,446,824)	(30,155,435)
Realized and Unrealized loss on marketable and other securities	0	0	0	(33,352)
Decrease of contingent liability	48,000	353,000	109,000	6,303,000
Other income	17,787	2,249	49,543	72,987
Interest expense	(1,946)	(2,086)	(4,583)	(5,320)
Loss before provision for income taxes	(1,336,802)	(4,657,215)	(5,292,864)	(23,818,120)
Benefit for income taxes	0	0	0	0
Net Loss	(1,336,802)	(4,657,215)	(5,292,864)	(23,818,120)
Preferred dividends	1,000,500	1,000,502	2,001,002	2,001,002
Net Loss attributable to cbdMD, Inc. common shareholders	$ (2,337,302)	$ (5,657,717)	$ (7,293,866)	$ (25,819,122)
Net Loss per share:
Basic earnings per share (in dollars per share)	$ (1.74)	$ (4.32)	$ (5.43)	$ (19.67)
Diluted earnings per share (in dollars per share)	$ (1.74)	$ (4.32)	$ (5.43)	$ (19.67)
Weighted average number of shares Basic: (in shares)	1,345,589	1,310,378	1,343,394	1,312,755
Weighted average number of shares Diluted: (in shares)	1,345,589	1,310,378	1,343,394	1,312,755